The altered gut microbiota strengthened the anticancer efficacy of hypofractionated radiotherapy in tumor-bearing mice by promoting antigen presentation and enhancing the functionality of tumor-infiltrating CD8+ T cells (Figure 3). This evidence concerns the gene CD8A and neoplasm.